Urinary Bladder, Neurogenic clinical trials

The registry lists 189 studies for Urinary Bladder, Neurogenic across more than 10 countries. 40 are recruiting or about to start. 93 of them are mainly about Urinary Bladder, Neurogenic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-03.

Get an email when these change. Save the Urinary Bladder, Neurogenic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 99
Recruiting: 26
Status unknown: 19
Terminated: 13
Active, not recruiting: 10
Not yet recruiting: 10

Phase

Phase 2: 22
Phase 3: 18
Phase 4: 12
Phase 1: 7
Early Phase 1: 5

Where

United States: 81
France: 27
Canada: 16
Switzerland: 15
Germany: 10
Turkey: 10

Who runs them

Medstar Health Research Institute (8) · The Methodist Hospital Research Institute (6) · The University of Texas Health Science Center, Houston (5) · Spinal Singularity (4) · University of Louisville (4) · Swiss Paraplegic Research, Nottwil (4) · University Hospital, Clermont-Ferrand (4) · VA Office of Research and Development (4)

What is being tested here

Drugs under test in Urinary Bladder, Neurogenic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Botulinum toxin type A	1	2	6
Gentamicins	1	1	3
Oxybutynin	1	1	3
Nitrous Oxide	1	0	2
Oxygen	1	0	1
Lidocaine	1	0	1
Ciprofloxacin	1	0	1
Lactobacillus crispatus	1	0	1
Mirabegron	0	1	3
Tamsulosin	0	1	3

Drug classes tested here Antimuscarinics 1 open

Coming up

3phase 3 studies under way

18studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Dec 2026Oxybutynin for Post-surgical Bladder Pain and Urgency · Phase 3 · University of California, Davis
Nov 2026A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections · TriHealth Inc.
Dec 2026Essential Oils for Urinary Symptoms in Multiple Sclerosis Patients · University of Oran 1
Dec 2026Measurement of Bladder Pressure With a Novel External Device (Cystomanometer) - Home Use · Christopher Cooper
Dec 2026Measurement of Bladder Pressure With a Novel External Device, Comparison to Urodynamics Testing · Christopher Cooper
Dec 2026Radio-frequency (RF) Bladder Monitor · McGill University Health Centre/Research Institute of the McGill University Health Centre
Jan 2027Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study · University of California, Los Angeles
Jan 2027Improving Pelvic Rehabilitation Using Epidural Stimulation After Spinal Cord Injury · University College, London
Mar 2027Bilateral Comparison of Unilateral Sacral Neuromodulation Test Stimulation in the Treatment of Neurogenic Bladder · Qilu Hospital of Shandong University
Mar 2027Effect of Chlorhexidine Gluconate Bladder Instillations in Patients With Chronic Suprapubic Catheters on Unplanned Healthcare Encounters and Quality of Life · Yale University

Who these studies take

Of the 26 Urinary Bladder, Neurogenic studies recruiting now, 12 (46%) set no upper age limit and 9 (35%) stop at 75 or younger. 7 (27%) take children under 18. 1 (4%) are for women only and 1 (4%) for men only; 1 (4%) take healthy volunteers.

Recruiting studies that take each age, of 26
Age	Women	Men
10	6 (23%)	6 (23%)
18	23 (88%)	22 (85%)
30	21 (81%)	21 (81%)
40	21 (81%)	21 (81%)
50	21 (81%)	21 (81%)
65	19 (73%)	19 (73%)
75	17 (65%)	17 (65%)
85	14 (54%)	14 (54%)

Across all 189 studies, recruiting or not: 38% stop at 75 or younger and 29% at 65; 29% take children; 7% are for women only and 4% for men only; 10% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Urinary Bladder, Neurogenic studies take

Of 51 interventional studies with no phase under Urinary Bladder, Neurogenic, half reached primary completion within 33 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Interventional, no phase	33 mo10–45 · 51 studies	—	36 mo12–45 · 47 studies
Observational	35 mo16–61 · 26 studies	—	—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Results posted2

Intravesical Lactobacillus to Reduce Urinary Symptoms After Spinal Cord InjuryNov 3, 2026NCT04373512
Recovery of Bladder and Sexual Function After Human Spinal Cord InjuryOct 29, 2026NCT04193709

Studies

Recruiting first, then most recently updated. Showing 50 of 189. Browse all 189 → or search them.